Literature DB >> 16695325

STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. III. A QUANTITATIVE METHOD FOR THE ESTIMATION OF SERUM ANTIFIBRINOLYSIN.

M H Kaplan1.   

Abstract

Year:  1946        PMID： 16695325      PMCID： PMC435571          DOI： 10.1172/JCI101715

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett
Journal:  Bacteriol Rev       Date:  1938-12

2.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

3.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

4.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.

Authors:  E J Cohn; J L Oncley; L E Strong; W L Hughes; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

5.  THE STREPTOCOCCAL ANTIFIBRINOLYSIN TEST IN CLINICAL USE.

Authors:  P L Boisvert
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

6.  DEVELOPMENT OF ANTIFIBRINOLYTIC PROPERTIES IN BLOOD OF PATIENTS WITH RHEUMATIC FEVER, CHRONIC INFECTIVE ARTHRITIS AND BACTERIAL ENDOCARDITIS.

Authors:  E Waaler
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

7.  STUDIES ON BLOOD COAGULATION: THE NATURE AND PROPERTIES OF A PROTEOLYTIC ENZYME DERIVED FROM PLASMA.

Authors:  M H Kaplan; H J Tagnon; C S Davidson; F H Taylor
Journal:  J Clin Invest       Date:  1942-09       Impact factor: 14.808
  7 in total
  6 in total

1.  The response of rheumatic and non-rheumatic children to streptolysin O concentrate.

Authors:  R W QUINN
Journal:  J Clin Invest       Date:  1957-06       Impact factor: 14.808

2.  ANTIGENIC AND ENZYME SYSTEM CHANGES IN BETA HEMOLYTIC STREPTOCOCCI RESISTANT TO PENICILLIN, STREPTOMYCIN, BACITRACIN AND AUREOMYCIN.

Authors:  H M Gezon; D M Fasan
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

3.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. I. THE DISSIMILARITY OF SERUM PROTEASE AND TRYPSIN AS INDICATED BY THE SEPARATE SPECIFICITIES OF THEIR KINASES, FIBRINOLYSIN AND ENTEROKINASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

4.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. IV. CLINICAL APPLICATION OF A QUANTITATIVE ANTIFIBRINOLYSIN TEST.

Authors: 
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

5.  QUANTITATIVE ANTISTREPTOKINASE STUDIES IN PATIENTS INFECTED WITH GROUP A HEMOLYTIC STREPTOCOCCI: A COMPARISON WITH SERUM ANTISTREPTOLYSIN AND GAMMA GLOBULIN LEVELS WITH SPECIAL REFERENCE TO THE OCCURRENCE OF RHEUMATIC FEVER.

Authors:  H C Anderson; H G Kunkel; M McCarty
Journal:  J Clin Invest       Date:  1948-07       Impact factor: 14.808

6.  A comparative study of antihyaluronidase, antistreptolysin "O," antistreptokinase, and streptococcal agglutination titers in patients with rheumatic fever, acute hemolytic streptococcal infections, rheumatoid arthritis and non-rheumatoid forms of arthritis.

Authors:  R W QUINN; S J LIAO
Journal:  J Clin Invest       Date:  1950-09       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.